Iman Imanirad

Moffitt Cancer Center

Papers

1

Total Citations

21

H-Index

1

About

Dr. Iman Imanirad is a leading oncologist and clinical researcher whose work centers on gastrointestinal malignancies, with a particular focus on rectal cancer treatment optimization and organ preservation strategies. Her most cited paper, "Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation" (2021, 21 citations), exemplifies her commitment to advancing personalized, de-escalation approaches that spare patients from permanent ostomies while maintaining oncologic outcomes. Through this work, she has helped refine neoadjuvant therapy sequencing and identify candidates for non-operative management—a paradigm shift in rectal cancer care. Dr. Imanirad’s research bridges the gap between aggressive multimodality treatment and quality-of-life considerations, offering evidence-based frameworks for clinicians navigating complex treatment decisions. Her contributions have been instrumental in expanding the role of total neoadjuvant therapy and watch-and-wait protocols, directly impacting clinical guidelines. With a growing portfolio of influential publications, Dr. Imanirad continues to shape the future of colorectal oncology, earning recognition as a thought leader in rectal cancer management and a dedicated advocate for patient-centered care.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation
21 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Moffitt Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago